Increase in PSA: Hi, my dad (age 6... - Advanced Prostate...

Advanced Prostate Cancer

22,348 members28,109 posts

Increase in PSA

Juju0713 profile image
11 Replies

Hi, my dad (age 62) was diagnosed with Stage 4 prostate cancer with multiple bone metastases in October 2022. He is also BRCA positive. He received 6 doses of docetaxel which he completed on 1/30/2023 and has also been taking apalutamide daily and eligard injections every 3 months. He just received his latest eligard injection 1 month late for when it was due (4 months vs 3 months) due to insurance issues. His PSA on 4/10/2023 was 2.9 and on 6/12/2023 was 4.3 so obviously an increase. Is this reason for concern or could it be due to the late eligard injection which he received also on 6/12? Just looking for some insight here and/or wondering what next steps might be whether it's rechecking PSA or if I am missing anything......Thank you.

Written by
Juju0713 profile image
Juju0713
To view profiles and participate in discussions please or .
Read more about...
11 Replies
tango65 profile image
tango65

Consider discussing with the doctors to treat him with ADT, plus abiraterone and olaparib, based in the Propel trial results.

ascopubs.org/doi/abs/10.120...

Juju0713 profile image
Juju0713 in reply totango65

thank you so much, I have read about the PARP inhibitors for BRCA mutation, I just wasn’t sure at what point they decided to add this on

meowlicious99 profile image
meowlicious99 in reply toJuju0713

i believe olaprib is never added early to treatment because of high toxicities and PC patients often live a long time and its impractical to be on PARP for that long.

That said, like all therapies, PARP are also being experimented with early administration. Depends mostly on clinician's judgement.

Wa40 profile image
Wa40

Hi Juju,

I am sorry for his Cancer, I would like to share my experience as somebody who I knows was facing the same situation .

LU-177 PSMA therapy, also known as Lutetium-177 PSMA therapy, is a targeted radioligand therapy used in the treatment of prostate cancer. It offers several benefits for patients, including:Targeted treatment: LU-177 PSMA therapy specifically targets prostate-specific membrane antigen (PSMA), a protein that is highly expressed on prostate cancer cells. This targeted approach allows for more precise and effective treatment of prostate cancer, while minimizing damage to healthy tissues.Extended survival: LU-177 PSMA therapy has shown promising results in extending the overall survival of patients with metastatic castration-resistant prostate cancer (mCRPC). It can help control the growth and spread of cancer cells and growing PSA value rapidly, potentially improving long-term outcomes.

I would definitely recommend this treatment for your Father, please try to get some information from his oncologist.

My friend got this treatment in Germany which was unfortunately cheaper then in states and quicker because it was very difficult for him to get this treatment in states as many people are waiting for this treatment already since months and mostly are undergoing to Clinical trials.

If you will need any help or if you will have some question regarding treatment you can write me any time.

Best Regards,

W.Daniel

Juju0713 profile image
Juju0713

thank you. So does this mean he is already castrate resistant after only a few months?

CAMPSOUPS profile image
CAMPSOUPS in reply toJuju0713

Maybe. If he can have another PSA in 2 to 3 weeks it will be more of an indicator of a trend or not. After my chemo 3 1/2 years ago it took awhile for my PSA to settle down. It reached a low of 5 or so then climbed to 8-9 where it stayed for a year.

Tango65's response is a good one. Olaparib is chosen for those with the BRCA+.

meowlicious99 profile image
meowlicious99 in reply toJuju0713

It possible but minor bumps happen for no reason also. One bump doesnt indicate CR.

I have heard that when giving chemo. The dying cancer cells sheds psa in the bloodstream so, may be the increase in psa due to that? Not sure but just a thought.

robert570 profile image
robert570

I went up and then went back down. Everyone's different. I was told they look at the average score versus a single reading. You should have a better reading at the next one. If it still goes up but not as much as the last one, then he might be heading in the right direction.

Vasili profile image
Vasili

Yes, it could be due to the late eligard injection

ishitasen profile image
ishitasen

Since your father psa levels are rising, most likely your father has devolop resistant to the inj. Eligard and Apalutamide and if there is further rise in psa levels your father might need to switch the treatment. Please discuss with your oncologist. There are multiple options available to you for further treatment, one of them is Pluvicto / Lu-177 PSMA therapy

Not what you're looking for?

You may also like...

Treatment Question

Hi to all, my dad (age 62) was diagnosed with Stage 4 prostate cancer with multiple bone metastases...
Juju0713 profile image

Psa doubling time

My husband's psa on 04/11/2023 was 3.16My husband's psa, 3 weeks later on 05/02/2023 is 6.21. It...

First PSA result after treatment

My dads original PSA was 39 before treatment. He is stage 4 (4+3 Gleason) and cancer spread to...

Drop in psa

I have been on arbitrone now for 3 months and psa went from 12.5 to 1, should it drop more or am I...
Muffin2019 profile image

Rise in PSA

My husband began this process in 2016 PSA 2.7 -- Gleason score 4+ After 40 radiation treatments...

Moderation team

Bethishere profile image
BethishereAdministrator
Number6 profile image
Number6Administrator
Darryl profile image
DarrylPartner

Content on HealthUnlocked does not replace the relationship between you and doctors or other healthcare professionals nor the advice you receive from them.

Never delay seeking advice or dialling emergency services because of something that you have read on HealthUnlocked.